A. Benjamin Suttle
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Hematology top 5%
- Acute Myeloid Leukemia Research
Papers in
- Pharmacology 11
- Pharmacogenetics and Drug Metabolism 11
-
- Drug Solubulity and Delivery Systems 4
- Co-authors
- Jeffrey P. Hodge (6 shared papers)Afshin Dowlati (4 shared papers)Lini N. Pandite (3 shared papers)Mohammed M. Dar (8 shared papers)Herbert I. Hurwitz (2 shared papers)Shermini Saini (1 shared paper)Diana M. Gibson (1 shared paper)Elmar Max Merkle (1 shared paper)
- Journals
- Investigational New Drugs (5 papers)Cancer Chemotherapy and Pharmacology (4 papers)Pharmaceutical Research (3 papers)British Journal of Cancer (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
A. Benjamin Suttle
32 papers receiving 1.9k citations
A. Benjamin Suttle's Hit Papers
Peers
Comparison fields: 5 of 78
- Pharmacology 427
- Hematology 214
- Pulmonary and Respiratory Medicine 399
- Pharmaceutical Science 79
- Pediatrics, Perinatology and Child Health 137
Countries citing papers authored by A. Benjamin Suttle
This map shows the geographic impact of A. Benjamin Suttle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Benjamin Suttle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Benjamin Suttle more than expected).
Fields of papers citing papers by A. Benjamin Suttle
This network shows the impact of papers produced by A. Benjamin Suttle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Benjamin Suttle. The network helps show where A. Benjamin Suttle may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Benjamin Suttle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia Hit paper breakdown → | 2018 | 378 |
| 2 | 2009 | 360 | |
| 3 | 2014 | 158 | |
| 4 | 2013 | 100 | |
| 5 | 2013 | 95 | |
| 6 | 2010 | 88 | |
| 7 | 2011 | 79 | |
| 8 | 2012 | 77 | |
| 9 | 2010 | 74 | |
| 10 | 1992 | 54 | |
| 11 | 2014 | 44 | |
| 12 | 2009 | 43 | |
| 13 | 2010 | 41 | |
| 14 | 2011 | 35 | |
| 15 | 2012 | 33 | |
| 16 | 2012 | 33 | |
| 17 | 2013 | 31 | |
| 18 | 2005 | 26 | |
| 19 | 2013 | 25 | |
| 20 | 2014 | 22 |
About A. Benjamin Suttle
A. Benjamin Suttle is a scholar working on Pharmacology, Pharmaceutical Science, Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 32 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Angiogenesis and VEGF in Cancer (10 papers), Drug Solubulity and Delivery Systems (4 papers), Cancer Treatment and Pharmacology (3 papers), Pharmaceutical studies and practices (3 papers), Mathematical Biology Tumor Growth (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Pharmacology (427 citations), Hematology (214 citations), Pulmonary and Respiratory Medicine (399 citations), Pharmaceutical Science (79 citations) and Pediatrics, Perinatology and Child Health (137 citations). A. Benjamin Suttle has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Jeffrey P. Hodge, Afshin Dowlati, Lini N. Pandite, Mohammed M. Dar, Herbert I. Hurwitz, Shermini Saini, Diana M. Gibson, Elmar Max Merkle, Kim L. R. Brouwer and Thangam Arumugham. Their work appears in journals such as Investigational New Drugs, Cancer Chemotherapy and Pharmacology, Pharmaceutical Research, British Journal of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.